Abstract
Four human head and neck xenograft (HNX) tumour lines grown in nude mice and two murine colon carcinomas (Colon 26 and 38) were tested for their sensitivity to 5-fluorouracil (5-FU) and its prodrug 5′deoxy-5-fluorouridine (Doxifluridine, 5′d-FUR). 5-FU sensitivity at the maximum tolerated dose (MTD) showed the following pattern; HNX-DU < HNX-KE = HNX-E = HNX-G < Colon 26 « Colon 38. The sensitivity pattern to 5′d-FUR was: HNX-DU < HNX-G < HNX-E < HNX-KE < Colon 38 < Colon 26. For HNX-KE, HNX-E and Colon 26 an increase in therapeutic efficacy was observed with 5′d-FUR as compared to 5-FU; Colon 38 was as sensitive to 5′d-FUR as to 5-FU. Plasma pharmacokinetics of 5′d-FUR and 5-FU were comparable in normal and nude mice. Metabolism of 5-FU and 5′d-FUR was studied in the tumours. Conversion of 5′d-FUR to 5-FU was highest in Colon 26 and 15–20 times lower in HNX-DU, HNX-KE and Colon 38. The Km for 5′d-FUR in all tumours was 1–2 mM. Further anabolism of 5-FU to fluorouridine (FUR) was 5–10 times higher than that of 5-FU to FUR in HNX tumours and 3 times in the colon tumours. 5-FU conversion to FUMP via FUR had the following pattern: Colon 26 » HNX-DU > HNX-G > HNX-E > HNX-KE » Colon 38; of 5-FU to FdUMP via FUdR: Colon 26 > HNX-DU = HNX-KE > HNX-E > HNX-G = Colon 38; and that of 5-FU to FUMP catalysed by orotate phosphoribosyl transferase (OPRT); Colon 26 ≥ Colon 38 > HNX-KE > HNX-E = HNX-DU = HNX-G. Only those tumours with a relatively high activity of OPRT were sensitive to 5′d-FUR. Colon 26, which has a very high rate of pyrimidine nucleoside phosphorylase, showed a relatively high increase in the therapeutic efficacy. It is concluded that a low rate of pyrimidine nucleoside phosphorylase is enough to convert 5′d-FUR to 5-FU; further anabolism of 5-FU catalysed by OPRT may be limiting and explain the differential sensitivity. © The Macmillan Press Ltd., 1989.
Cite
CITATION STYLE
Peters, G. J., Braakhuis, B. J. M., De Bruijn, E. A., Laurensse, E. J., Van Walsum, M., & Pinedo, H. M. (1989). Enhanced therapeutic efficacy of 5′deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes. British Journal of Cancer, 59(3), 327–334. https://doi.org/10.1038/bjc.1989.65
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.